查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1448678

全球器官晶片市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Organs-on-chips Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 351 Pages | 商品交期: 最快1-2個工作天內

價格

全球器官晶片市場需求預計將從2023年的1.1726億美元達到2032年的近15.4144億美元，2024-2032年研究期間的CAGR為33.14%。

器官晶片是一種微流體裝置，可以在微型規模上複製人體器官的結構和功能特徵。這些晶片包含活細胞並模擬生理環境，使研究人員能夠研究器官層面對藥物和疾病的反應。該技術為傳統動物測試提供了更準確、更合乎道德的替代方案，為藥物開發和個人化醫療提供了人類生物學的寶貴見解。

市場動態

由於倫理問題以及對更多與人類相關的研究模型的需求，對傳統動物測試方法替代方法的需求不斷增加，推動了採用。此外，對個人化醫療和藥物開發的關注放大了準確的體外測試平台的重要性。器官晶片技術提供了一個更生理相關的環境，有助於更好地理解器官層面的反應。此外，製藥公司和器官晶片製造商之間的合作有助於市場成長，促進創新和研究。精準醫療的推動，加上微加工技術的進步，進一步加速了市場擴張。隨著製藥和生物技術產業優先考慮更安全、更有效率的藥物開發流程，器官晶片市場可望持續成長，徹底改變臨床前測試的模式。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球器官晶片市場的各個細分市場進行了包容性評估。器官晶片產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

晶片器官市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按類型

  • 產品（肝臟晶片、肺晶片、心臟晶片、腎臟晶片、其他產品）
  • 服務

按材質

  • 聚二甲基矽氧烷 (Pdms)
  • 聚合物
  • 玻璃

按型號類型

  • 單一器官模型
  • 多重器官模型

按應用

  • 藥物發現
  • 毒性測試
  • 疾病建模
  • 個人化醫療
  • 其他

按最終用戶

  • 製藥和生物技術公司
  • 學術及研究機構
  • 其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的器官晶片市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。器官晶片市場的主要參與者包括 Altis Biosystems、AlveoliX AG、Axosim、Bi/ond Solutions BV、Cherry Biotech、CN-Bio、Emulate, Inc.、Hesperos, Inc.、Insphero、MesoBioTech、Mimetas BV、 Nortis Inc.、 React4Life、TARA Biosystems（Valo Health）、TissUse GmbH。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：器官晶片 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按類型分類的市場吸引力分析
    • 按材料分類的市場吸引力分析
    • 按模型類型分類的市場吸引力分析
    • 市場吸引力分析：依應用分類
    • 最終用戶的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球晶片器官市場分析：按類型

  • 按類型概述
  • 歷史和預測數據
  • 按類型分析
  • 產品（肝臟晶片、肺晶片、心臟晶片、腎臟晶片、其他產品）
  • 服務

第 6 章：全球器官晶片市場分析：依材料分類

  • 按材料概述
  • 歷史和預測數據
  • 按材料分析
  • 聚二甲基矽氧烷 (Pdms)
  • 聚合物
  • 玻璃

第 7 章：全球晶片器官市場分析：依模型類型

  • 按型號類型概述
  • 歷史和預測數據
  • 按模型類型分析
  • 單一器官模型
  • 多重器官模型

第 8 章：全球晶片器官市場分析：依應用分類

  • 概述：按應用
  • 歷史和預測數據
  • 分析：按應用
  • 藥物發現
  • 毒性測試
  • 疾病建模
  • 個人化醫療
  • 其他

第 9 章：全球晶片器官市場分析：依最終用戶分類

  • 最終用戶概述
  • 歷史和預測數據
  • 最終用戶分析
  • 製藥和生物技術公司
  • 學術及研究機構
  • 其他

第 10 章：全球晶片器官市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 11 章：器官晶片公司的競爭格局

  • 器官晶片市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 12 章：公司簡介

  • 公司股份分析
  • 市場集中度
  • Altis Biosystems
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • AlveoliX AG
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Axosim
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Bi/ond Solutions BV
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Cherry Biotech
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • CN-Bio
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Emulate Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Hesperos Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Insphero
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • MesoBioTech
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Mimetas BV
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Nortis Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • React4Life
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • TARA Biosystems (Valo Health)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • TissUse GmbH.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

Product Code: VMR112113662

The global demand for Organs-on-chips Market is presumed to reach the market size of nearly USD 1541.44 Million by 2032 from USD 117.26 Million in 2023 with a CAGR of 33.14% under the study period 2024 - 2032.

Organs-on-chips are microfluidic devices that replicate the structural and functional traits of human organs on a miniature scale. These chips contain living cells and simulate the physiological environment, allowing researchers to study organ-level responses to drugs and diseases. This technology offers a more accurate and ethical alternative to traditional animal testing, providing valuable insights into human biology for drug development and personalized medicine.

MARKET DYNAMICS

The increasing demand for alternatives to traditional animal testing methods due to ethical concerns and the need for more human-relevant research models drives adoption. Additionally, the focus on personalized medicine and drug development amplifies the significance of accurate in vitro testing platforms. The organs-on-chips technology offers a more physiologically relevant environment, enabling a better understanding of organ-level responses. Moreover, collaborations between pharmaceutical companies and organs-on-chips manufacturers contribute to market growth, fostering innovation and research. The push for precision medicine, coupled with advancements in microfabrication techniques, further accelerates market expansion. As the pharmaceutical and biotechnology industries prioritize safer and more efficient drug development processes, the organs-on-chips market is poised for sustained growth, revolutionizing the landscape of preclinical testing.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of organs-on-chips. The growth and trends of organs-on-chips industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the organs-on-chips market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Product (Liver-On-Chip, Lung-On-Chip, Heart-On-Chip, Kidney-On-Chip, Other Products)
  • Service

By Material

  • Polydimethylsiloxane (Pdms)
  • Polymer
  • Glass

By Model Type

  • Single-Organ Model
  • Multi-Organ Model

By Application

  • Drug Discovery
  • Toxicity Testing
  • Disease Modeling
  • Personalized Medicine
  • Other

By End-User

  • Pharmaceutical And Biotechnology Companies
  • Academic And Research Institutes
  • Other

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Organs-on-chips market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Organs-on-chips market include Altis Biosystems, AlveoliX AG, Axosim, Bi/ond Solutions B.V, Cherry Biotech, CN-Bio, Emulate, Inc., Hesperos, Inc., Insphero, MesoBioTech, Mimetas B.V., Nortis Inc., React4Life, TARA Biosystems (Valo Health), TissUse GmbH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . ORGANS-ON-CHIPS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Material
    • 3.7.3 Market Attractiveness Analysis By Model Type
    • 3.7.4 Market Attractiveness Analysis By Application
    • 3.7.5 Market Attractiveness Analysis By End-User
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ORGANS-ON-CHIPS MARKET ANALYSIS BY TYPE

  • 5.1 Overview by Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Type
  • 5.4 Product (Liver-On-Chip, Lung-On-Chip, Heart-On-Chip, Kidney-On-Chip, Other Products) Historic and Forecast Sales by Regions
  • 5.5 Service Historic and Forecast Sales by Regions

6 . GLOBAL ORGANS-ON-CHIPS MARKET ANALYSIS BY MATERIAL

  • 6.1 Overview by Material
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Material
  • 6.4 Polydimethylsiloxane (Pdms) Historic and Forecast Sales by Regions
  • 6.5 Polymer Historic and Forecast Sales by Regions
  • 6.6 Glass Historic and Forecast Sales by Regions

7 . GLOBAL ORGANS-ON-CHIPS MARKET ANALYSIS BY MODEL TYPE

  • 7.1 Overview by Model Type
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Model Type
  • 7.4 Single-Organ Model Historic and Forecast Sales by Regions
  • 7.5 Multi-Organ Model Historic and Forecast Sales by Regions

8 . GLOBAL ORGANS-ON-CHIPS MARKET ANALYSIS BY APPLICATION

  • 8.1 Overview by Application
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Application
  • 8.4 Drug Discovery Historic and Forecast Sales by Regions
  • 8.5 Toxicity Testing Historic and Forecast Sales by Regions
  • 8.6 Disease Modeling Historic and Forecast Sales by Regions
  • 8.7 Personalized Medicine Historic and Forecast Sales by Regions
  • 8.8 Other Historic and Forecast Sales by Regions

9 . GLOBAL ORGANS-ON-CHIPS MARKET ANALYSIS BY END-USER

  • 9.1 Overview by End-User
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by End-User
  • 9.4 Pharmaceutical And Biotechnology Companies Historic and Forecast Sales by Regions
  • 9.5 Academic And Research Institutes Historic and Forecast Sales by Regions
  • 9.6 Other Historic and Forecast Sales by Regions

10 . GLOBAL ORGANS-ON-CHIPS MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2. North America By Segment Sales Analysis
    • 10.3.3. North America By Country Sales Analysis
    • 10.3.4. United State Sales Analysis
    • 10.3.5. Canada Sales Analysis
    • 10.3.6. Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2. Europe by Segment Sales Analysis
    • 10.4.3. Europe by Country Sales Analysis
    • 10.4.4. United Kingdom Sales Analysis
    • 10.4.5. France Sales Analysis
    • 10.4.6. Germany Sales Analysis
    • 10.4.7. Italy Sales Analysis
    • 10.4.8. Russia Sales Analysis
    • 10.4.9. Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2. Asia Pacific by Segment Sales Analysis
    • 10.5.3. Asia Pacific by Country Sales Analysis
    • 10.5.4. China Sales Analysis
    • 10.5.5. India Sales Analysis
    • 10.5.6. Japan Sales Analysis
    • 10.5.7. South Korea Sales Analysis
    • 10.5.8. Australia Sales Analysis
    • 10.5.9. South East Asia Sales Analysis
    • 10.5.10. Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2. Latin America by Segment Sales Analysis
    • 10.6.3. Latin America by Country Sales Analysis
    • 10.6.4. Brazil Sales Analysis
    • 10.6.5. Argentina Sales Analysis
    • 10.6.6. Peru Sales Analysis
    • 10.6.7. Chile Sales Analysis
    • 10.6.8. Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2. Middle East & Africa by Segment Sales Analysis
    • 10.7.3. Middle East & Africa by Country Sales Analysis
    • 10.7.4. Saudi Arabia Sales Analysis
    • 10.7.5. UAE Sales Analysis
    • 10.7.6. Israel Sales Analysis
    • 10.7.7. South Africa Sales Analysis
    • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE ORGANS-ON-CHIPS COMPANIES

  • 11.1. Organs-On-Chips Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12 . COMPANY PROFILES OF ORGANS-ON-CHIPS INDUSTRY

  • 12.1. Company Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Altis Biosystems
    • 12.3.1. Company Overview
    • 12.3.2. Company Revenue
    • 12.3.3. Products
    • 12.3.4. Recent Developments
  • 12.4. AlveoliX AG
    • 12.4.1. Company Overview
    • 12.4.2. Company Revenue
    • 12.4.3. Products
    • 12.4.4. Recent Developments
  • 12.5. Axosim
    • 12.5.1. Company Overview
    • 12.5.2. Company Revenue
    • 12.5.3. Products
    • 12.5.4. Recent Developments
  • 12.6. Bi/ond Solutions B.V
    • 12.6.1. Company Overview
    • 12.6.2. Company Revenue
    • 12.6.3. Products
    • 12.6.4. Recent Developments
  • 12.7. Cherry Biotech
    • 12.7.1. Company Overview
    • 12.7.2. Company Revenue
    • 12.7.3. Products
    • 12.7.4. Recent Developments
  • 12.8. CN-Bio
    • 12.8.1. Company Overview
    • 12.8.2. Company Revenue
    • 12.8.3. Products
    • 12.8.4. Recent Developments
  • 12.9. Emulate Inc.
    • 12.9.1. Company Overview
    • 12.9.2. Company Revenue
    • 12.9.3. Products
    • 12.9.4. Recent Developments
  • 12.10. Hesperos Inc.
    • 12.10.1. Company Overview
    • 12.10.2. Company Revenue
    • 12.10.3. Products
    • 12.10.4. Recent Developments
  • 12.11. Insphero
    • 12.11.1. Company Overview
    • 12.11.2. Company Revenue
    • 12.11.3. Products
    • 12.11.4. Recent Developments
  • 12.12. MesoBioTech
    • 12.12.1. Company Overview
    • 12.12.2. Company Revenue
    • 12.12.3. Products
    • 12.12.4. Recent Developments
  • 12.13. Mimetas B.V.
    • 12.13.1. Company Overview
    • 12.13.2. Company Revenue
    • 12.13.3. Products
    • 12.13.4. Recent Developments
  • 12.14. Nortis Inc.
    • 12.14.1. Company Overview
    • 12.14.2. Company Revenue
    • 12.14.3. Products
    • 12.14.4. Recent Developments
  • 12.15. React4Life
    • 12.15.1. Company Overview
    • 12.15.2. Company Revenue
    • 12.15.3. Products
    • 12.15.4. Recent Developments
  • 12.16. TARA Biosystems (Valo Health)
    • 12.16.1. Company Overview
    • 12.16.2. Company Revenue
    • 12.16.3. Products
    • 12.16.4. Recent Developments
  • 12.17. TissUse GmbH.
    • 12.17.1. Company Overview
    • 12.17.2. Company Revenue
    • 12.17.3. Products
    • 12.17.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis by Type (USD MN)
  • Product (Liver-On-Chip, Lung-On-Chip, Heart-On-Chip, Kidney-On-Chip, Other Products) Market Sales by Geography (USD MN)
  • Service Market Sales by Geography (USD MN)
  • Analysis Market by Material (USD MN)
  • Polydimethylsiloxane (Pdms) Market Sales by Geography (USD MN)
  • Polymer Market Sales by Geography (USD MN)
  • Glass Market Sales by Geography (USD MN)
  • Analysis by Model Type (USD MN)
  • Single-Organ Model Market Sales by Geography (USD MN)
  • Multi-Organ Model Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Drug Discovery Market Sales by Geography (USD MN)
  • Toxicity Testing Market Sales by Geography (USD MN)
  • Disease Modeling Market Sales by Geography (USD MN)
  • Personalized Medicine Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Analysis by End-User (USD MN)
  • Pharmaceutical And Biotechnology Companies Market Sales by Geography (USD MN)
  • Academic And Research Institutes Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Global Organs-On-Chips Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Organs-On-Chips Report
  • Market Research Process
  • Market Research Methodology
  • Global Organs-On-Chips Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Material
  • Market Attractiveness Analysis by Model Type
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End-User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Product (Liver-On-Chip, Lung-On-Chip, Heart-On-Chip, Kidney-On-Chip, Other Products) Market Sales by Geography (USD MN)
  • Service Market Sales by Geography (USD MN)
  • Global Market Analysis by Material (USD MN)
  • Polydimethylsiloxane (Pdms) Market Sales by Geography (USD MN)
  • Polymer Market Sales by Geography (USD MN)
  • Glass Market Sales by Geography (USD MN)
  • Global Market Analysis by Model Type (USD MN)
  • Single-Organ Model Market Sales by Geography (USD MN)
  • Multi-Organ Model Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Drug Discovery Market Sales by Geography (USD MN)
  • Toxicity Testing Market Sales by Geography (USD MN)
  • Disease Modeling Market Sales by Geography (USD MN)
  • Personalized Medicine Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Global Market Analysis by End-User (USD MN)
  • Pharmaceutical And Biotechnology Companies Market Sales by Geography (USD MN)
  • Academic And Research Institutes Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.